Quantum Biopharma (QNTM) Invested Capital (2024 - 2026)

Quantum Biopharma has reported Invested Capital for 3 years, with the latest figure at $300549.0 in Q1 2026.

• Quarterly Invested Capital fell 72.37% year-over-year to $300549.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 223.43% YoY) and the FY2025 annual result came in at $1.3 million, up 110.1% from the prior year.
• Invested Capital eased to $300549.0 in Q1 2026 per QNTM's latest filing, from $1.3 million in the prior quarter.
• Over five years, Invested Capital peaked at $2.0 million in Q3 2025 and troughed at $300549.0 in Q1 2026.
• A 3-year average of $1.2 million and a median of $1.2 million in 2025 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2025 and 2026: Invested Capital jumped 110.1% in 2025, then sank 72.37% in 2026.
• Over 3 years, Invested Capital stood at $619029.0 in 2024, then jumped by 110.1% to $1.3 million in 2025, then slumped by 76.89% to $300549.0 in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $300549.0, $1.3 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.